Pharmaceutical tariffs, as proposed by President Donald Trump, aim to create manufacturing jobs in the United States, limit ...

Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...

President Trump and British Prime Minister Keir Starmer announced a new trade agreement. Other countries, including China, ...

The imposition of tariffs on pharmaceutical imports - either directly or indirectly through raw materials and active ...

BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, May 5, 2025, at 8:00 a.m. EDT (2:00 p.m. CEST) to report its financial results ...

Baxter International, a prominent health care and pharmaceutical manufacturer, reports that President Trump's tariffs will ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

Whilst 2025 outlooks include cost impact from existing tariffs, companies have not adjusted their guidance for future ...

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

Pfizer CEO Albert Bourla said the pharmaceutical ... the company behind fast food chains like Taco Bell and Pizza Hut, expects little impact from tariffs on its supply chain, CFO Chris Turner ...

Pfizer reaffirmed $10–$15 billion for business ... concerns are central to U.S. drug manufacturing strategy, not tariffs alone. Feel unsure about the market’s next move? Copy trade alerts ...